Physician profile
Lorena Forster
NPI 1881259562
$1,669.66
in general payments reported to CMS, 2019-2025
16 companies · $359 in 2025
The $359 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $95.83 · 2022: $328 · 2023: $620 · 2024: $267 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,009 · Education: $237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,008.70 |
| Education | $236.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $601.13 | 2021-2025 | Dupixent |
| Genzyme Corporation | $353.40 | 2021-2025 | |
| Glaxosmithkline, LLC. | $191.71 | 2022-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Sanofi-Aventis U.S. LLC | $79.93 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $78.61 | 2022-2024 | Fasenra |
| Blueprint Medicines Corporation | $58.73 | 2023 | Ayvakit |
| Optinose US, INC. | $55.61 | 2025 | |
| Octapharma USA, INC. | $55.49 | 2022 | |
| Ars Pharmaceuticals Operations, INC. | $48.16 | 2025 | Neffy |
| Amgen INC. | $37.48 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $28.46 | 2025 | Zoryve |
| Incyte Corporation | $21.79 | 2024 | Opzelura |
| Csl Behring | $20.82 | 2023 | Haegarda |
| Baxter Healthcare | $19.12 | 2023 | Hillrom - Vest System Model 105 Home Care |
| Takeda Pharmaceuticals U.S.A., INC. | $15.93 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $3.29 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lorena Forster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.